Table 1.
The semi-mature phenotype and tolerogenic messenger RNA (mRNA) expression profile of tolerance-inducing dendritic cells (TolDCs) was not affected by mRNA electroporation.
Control DCs |
TolDCs |
||||||
---|---|---|---|---|---|---|---|
Non-EP | Mock EP | C–C chemokine receptor 5 (CCR5) EP | Non-EP | Mock EP | CCR5 EP | ||
Protein expression | |||||||
CD80 | % | 92.45 ± 1.69 | 87.97 ± 2.85 | 86.13 ± 3.92 | 20.18 ± 9.85*** | 16.45 ± 8.01*** | 16.37 ± 8.33*** |
MFI | 120.47 ± 12.09 | 81.15 ± 6.44+++ | 78.28 ± 6.81+++ | 40.60 ± 5.98*** | 39.35 ± 5.16*** | 38.23 ± 5.26*** | |
CD83 | % | 90.95 ± 1.15 | 82.58 ± 2.22 | 82.55 ± 2.65 | 24.83 ± 7.56*** | 23.48 ± 6.58*** | 22.22 ± 6.90*** |
MFI | 29.50 ± 2.90 | 22.88 ± 3.01+++ | 23.55 ± 3.28++ | 16.48 ± 3.59*** | 15.67 ± 3.32*** | 15.65 ± 3.40*** | |
CD86 | % | 99.33 ± 0.26 | 99.20 ± 0.30 | 99.10 ± 0.36 | 93.03 ± 2.01** | 92.73 ± 2.05** | 93.52 ± 2.13** |
MFI | 762.33 ± 55.37 | 508.50 ± 82.98++ | 471.67 ± 8,797+++ | 212.65 ± 44.15*** | 165.17 ± 36.28*** | 183.30 ± 40.67*** | |
HLA-DR | % | 93.87 ± 5.85 | 92.95 ± 6.39 | 93.07 ± 6.43 | 88.82 ± 5.18* | 88.02 ± 5.65 | 87.87 ± 5.64* |
MFI | 337.00 ± 58.42 | 220.33 ± 25.92+ | 234.33 ± 21.40 | 97.05 ± 34.91*** | 75.95 ± 19.53** | 75.07 ± 21.63** | |
mRNA expression | |||||||
LILRB4 | RNE | 0.28570 ± 0.01755 | 0.29916 ± 0.00928 | 0.25645 ± 0.01017 | 1.90876 ± 0.11275*** | 1.95846 ± 0.196215*** | 1.96215 ± 0.2019*** |
TLR2 | RNE | 0.10107 ± 0.00992 | 0.11338 ± 0.00490 | 0.10679 ± 0.00676 | 1.74427 ± 0.15793*** | 1.95846 ± 0.22097*** | 2.04363 ± 0.27273*** |
Mean ± SEM of six replicates (protein expression) and three replicates (mRNA expression).
+Denotes a statistically significant difference from nonelectroporated DCs, within control DC or tolDC conditions.
*Denotes a statistically significant difference from the corresponding (i.e., non-EP, mock EP, or CCR5 EP) control DC conditions.
*/+p < 0.05, **/++p < 0.01, ***/+++p < 0.001.
MFI, mean fluorescence intensity; RNE, relative normalized expression.